KUALA LUMPUR: Pharmaniaga Bhd’s wholly-owned subsidiary, Pharmaniaga Lifescience Sdn Bhd, has signed an agreement with the government through the Health Ministry to supply and distribute 200,000 doses of the imported finished product of Covid-19 vaccine by Sinovac.
The vaccine has been developed and manufactured by Sinovac Life Sciences Co Ltd, a subsidiary of Sinovac Biotech Ltd.
“The agreement and collaboration contemplated therein will serve as a platform for Pharmaniaga to further strengthen its vaccine business and grow the sector in Malaysia.
“It will also provide the company with another income stream which will contribute to its profitability in the future,” Pharmaniaga said in a filing with Bursa Malaysia today.
The company added that this collaboration was expected to contribute positively to the Group’s future earnings and earnings per share for the financial year ending Dec 31, 2021. – Bernama
